Oestrogens, prolactin, hypothalamic-pituitary-gonadal axis, and schizophrenic psychoses

详细信息    查看全文

• 作者：Prof Anita Riecher-Rö ; ssler ; MD^a ; ^{anita.riecher@upkbs.ch}
• 刊名：The Lancet Psychiatry
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：4
• 期：1
• 页码：63-72
• 全文大小：258 K
• 卷排序：4

文摘

Interest is growing in the potential effect of gonadal hormones, prolactin, and the hypothalamic–pituitary–gonadal axis in schizophrenic psychoses. Many studies from clinical, epidemiological, and fundamental research have confirmed that oestradiol, the main component of oestrogens, can have protective effects in schizophrenic psychoses. Furthermore, many patients with schizophrenic psychoses—even in the untreated prodromal stages—have hyperprolactinaemia and gonadal dysfunction, with oestrogen deficiency in women and testosterone deficiency in men. The understanding of the pathogenetic mechanisms underlying these findings could contribute to a better understanding of the aetiopathogenesis of schizophrenic psychoses and improve therapeutic approaches. In this Series paper, we aim to review methodologically sound studies in this area, propose a theory to explain these findings in the context of psychosis, and suggest therapeutic strategies and implications for further research.